Literature DB >> 21666394

Using electronic health information to risk-stratify rates of Clostridium difficile infection in US hospitals.

Marya D Zilberberg1, Ying P Tabak, Dawn M Sievert, Karen G Derby, Richard S Johannes, Xiaowu Sun, L Clifford McDonald.   

Abstract

BACKGROUND: Expanding hospitalized patients' risk stratification for Clostridium difficile infection (CDI) is important for improving patient safety. We applied definitions for hospital-onset (HO) and community-onset (CO) CDI to electronic data from 85 hospitals between January 2007 and June 2008 to identify factors associated with higher HO CDI rates.
METHODS: Nonrecurrent CDI cases were identified among adult (≥ 18-year-old) inpatients by a positive C. difficile toxin assay result more than 8 weeks after any previous positive result. Case categories included HO, CO-hospital associated (CO-HA), CO-indeterminate hospital association (CO-IN), and CO-non-hospital associated (CO-NHA). C. difficile testing intensity (CDTI) was defined as the total number of C. difficile tests performed, normalized to the number of patients with at least 1 C. difficile toxin test recorded. We calculated both the incidence density and the prevalence of CDI where appropriate. We fitted a multivariable Poisson model to identify factors associated with higher HO CDI rates.
RESULTS: Among 1,351,156 unique patients with 2,022,213 admissions, 9,803 cases of CDI were identified; of these, 50.6% were HO, 17.4% were CO-HA, 9.0% were CO-IN, and 23.0% were CO-NHA. The incidence density of HO was 6.3 per 10,000 patient-days. The prevalence of CO CDI on admission was, per 10,000 admissions, 8.4 for CO-HA, 4.4 for CO-IN, and 11.1 for CO-NHA. Factors associated (P < .0001) with higher HO CDI rates included older age, higher CO-NHA prevalence on admission, and increased CDTI.
CONCLUSION: Electronic health information can be leveraged to risk-stratify HO CDI rates by patient age and CO-NHA prevalence on admission. Hospitals should optimize diagnostic testing to improve patient care and measured CDI rates.

Entities:  

Mesh:

Year:  2011        PMID: 21666394     DOI: 10.1086/660360

Source DB:  PubMed          Journal:  Infect Control Hosp Epidemiol        ISSN: 0899-823X            Impact factor:   3.254


  22 in total

1.  Prevalence and risk factors for asymptomatic Clostridium difficile carriage.

Authors:  Faisal Alasmari; Sondra M Seiler; Tiffany Hink; Carey-Ann D Burnham; Erik R Dubberke
Journal:  Clin Infect Dis       Date:  2014-04-21       Impact factor: 9.079

2.  Blood Culture Turnaround Time in U.S. Acute Care Hospitals and Implications for Laboratory Process Optimization.

Authors:  Ying P Tabak; Latha Vankeepuram; Gang Ye; Kay Jeffers; Vikas Gupta; Patrick R Murray
Journal:  J Clin Microbiol       Date:  2018-11-27       Impact factor: 5.948

3.  Predicting the risk for hospital-onset Clostridium difficile infection (HO-CDI) at the time of inpatient admission: HO-CDI risk score.

Authors:  Ying P Tabak; Richard S Johannes; Xiaowu Sun; Carlos M Nunez; L Clifford McDonald
Journal:  Infect Control Hosp Epidemiol       Date:  2015-03-10       Impact factor: 3.254

4.  Comparison of Illumigene, Simplexa, and AmpliVue Clostridium difficile molecular assays for diagnosis of C. difficile infection.

Authors:  E Deak; S A Miller; R M Humphries
Journal:  J Clin Microbiol       Date:  2013-12-18       Impact factor: 5.948

5.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

6.  Uncovering the role of antibiotics in the transmission of multidrug-resistant organisms.

Authors:  L Clifford McDonald
Journal:  JAMA Intern Med       Date:  2015-04       Impact factor: 21.873

7.  Point-Counterpoint: Active Surveillance for Carriers of Toxigenic Clostridium difficile Should Be Performed To Guide Prevention Efforts.

Authors:  L Clifford McDonald; Daniel J Diekema
Journal:  J Clin Microbiol       Date:  2018-07-26       Impact factor: 5.948

Review 8.  Comparison of pediatric and adult antibiotic-associated diarrhea and Clostridium difficile infections.

Authors:  Lynne Vernice McFarland; Metehan Ozen; Ener Cagri Dinleyici; Shan Goh
Journal:  World J Gastroenterol       Date:  2016-03-21       Impact factor: 5.742

9.  Healthcare facility-onset, healthcare facility-associated Clostridioides difficile infection in Veterans with spinal cord injury and disorder.

Authors:  Charlesnika T Evans; Margaret Fitzpatrick; Swetha Ramanathan; Stephen M Kralovic; Stephen P Burns; Barry Goldstein; Bridget Smith; Dale N Gerding; Stuart Johnson
Journal:  J Spinal Cord Med       Date:  2019-10-30       Impact factor: 1.985

10.  Clostridium difficile infection in Italian urban hospitals: data from 2006 through 2011.

Authors:  Stefano Di Bella; Maria Musso; Maria A Cataldo; Marcello Meledandri; Eugenio Bordi; Daniela Capozzi; Maria C Cava; Patrizia Chiaradonna; Grazia Prignano; Nicola Petrosillo
Journal:  BMC Infect Dis       Date:  2013-03-22       Impact factor: 3.090

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.